Cardiomyopathy Clinical Trials in Madrid
5 recruitingMadrid, Spain
Showing 1–5 of 5 trials
Recruiting
Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Novo Nordisk A/S1,280 enrolled285 locationsNCT07207811
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Obstructive Hypertrophic Cardiomyopathy
Bristol-Myers Squibb1,600 enrolled99 locationsNCT05489705
Recruiting
Genetic Characterization of Patients With Arrhythmia-Induced Cardiomyopathy
CardiomyopathyArrhythmiaArrhythmia-induced Cardiomyopathy (AiCM)
Hospital Universitario 12 de Octubre109 enrolled4 locationsNCT06896266
Recruiting
CARdiomyopathy in Type 2 DIAbetes Mellitus
Cardiomyopathy, Diabetic
Institut National de la Santé Et de la Recherche Médicale, France1,600 enrolled17 locationsNCT04303364
Recruiting
Not Applicable
Study of Personalized Allocation of Defibrillators in Non-ischemic Heart Failure (SPANISH-1)
Non-ischemic Dilated Cardiomyopathy
Consorcio Centro de Investigación Biomédica en Red (CIBER)900 enrolled31 locationsNCT06055504